The inexorable rise in healthcare costs, combined with increasing consumer unaffordability, payment reform and fraying of the ACA (“Obamacare”), is leading to strategic uncertainty and for more than a few providers, financial challenges. Provider consolidation has altered the basis of competition from individual facilities to a “parent” managing a portfolio of institutions with mixed performance.
In this report, Alvarez & Marsal (A&M) provides its perspective on the transformative actions required by providers to succeed in an at-risk, value-based environment. Traditional restructuring and performance improvement activities are required, but alone, are not sufficient to succeed in the future.
Click here to download the full report.
E-Invoicing in Germany: Validation as the New Compliance Backbone
October 28, 2025
This article explores the implications of e-Invoicing changes in Germany, with a particular focus on validation as the new compliance backbone.
EU VAT Quarterly Wrap-up –– Q3 2025
October 28, 2025
In this Q3 2025 edition of our VAT Quarterly Wrap-up, we address three VAT topics which kept the CJEU busy in the third quarter of 2025. Alongside these cases, we selected a number of developments relevant for companies active in EU Member States.
Rich Behrens Selected for ABI's 2025 “40 Under 40” Achievement
October 27, 2025
Managing Director Rich Behrens has been selected as an honoree for the American Bankruptcy Institute’s (ABI) 2025 “40 Under 40” Award.
CRLs Unveiled: Converting FDA Transparency into a Market Advantage
October 27, 2025
With the FDA’s disclosure of 200 Complete Response Letters (CRLs), leadership teams now have an unprecedented insight into regulatory decision-making to glean patterns, challenge assumptions, and strengthen governance before avoidable failures occur.
